Loading...
NYSE: PFE
Pfizer Inc.
Healthcare · Drug Manufacturers - General
●S&P 500 since 1957
Market Cap
$155.60B
52w High
$27.94
52w Low
$20.92
P/E
20.01
Volume
18.12M
Outstanding Shares
5.69B
Company profile
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
CEOAlbert Bourla
SectorHealthcare
IndustryDrug Manufacturers - General
Employees81,000
IPO dateJun 1, 1972
Valuation
Forward P/E—
EV/EBITDA13.76
Enterprise value$207.77B
Stock splits
Nov 17, 2020527:500
Jul 1, 19993:1
Jul 1, 19972:1
Jul 3, 19952:1
Apr 1, 19912:1
Jul 1, 19832:1
Profitability & growth
Revenue growth-1.16%
Gross margin70.33%▲6.94%vs FY2024
Operating margin24.67%▼4.78%vs FY2024
ROE8.99%▼1.18%vs FY2024
Analyst consensus
RatingHold
Target price$27.50▲0.49%
15
Buy
22
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
View
EPS
Actual vs estimate by quarter
Q2FY25
ActualEst.
$0.78
$0.58
Q3FY25
ActualEst.
$0.87
$0.63
Q4FY25
ActualEst.
$0.66
$0.57
Q1FY26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q2FY25
ActualEst.
$14.65B
$13.56B
Q3FY25
ActualEst.
$16.65B
$16.5B
Q4FY25
ActualEst.
$17.56B
$16.85B
Q1FY26
Next Est.
—